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The VAPB/ALS8 major sperm protein domain (vMSP)
is implicated in amyotrophic lateral sclerosis and
spinal muscular atrophy, yet its function in the ner-
vous system is not well understood. In Caenorhabdi-
tis elegans and Drosophila, the vMSP is cleaved
from its transmembrane anchor and secreted in a
cell type-specific fashion. We show that vMSPs
secreted by neurons act on Lar-like protein-tyrosine
phosphatase and Roundabout growth cone guid-
ance receptors expressed in striated muscle. This
signaling pathway promotes Arp2/3-dependent actin
remodeling and mitochondrial localization to actin-
rich muscle I-bands. C. elegans VAPB mutants have
mitochondrial localization, morphology, mobility,
and fission/fusion defects that are suppressed
by Lar-like receptor or Arp2/3 inactivation. Hence,
growth cone guidance receptor pathways that
remodel the actin cytoskeleton have unanticipated
effects on mitochondrial dynamics. We propose
that neurons secrete vMSPs to promote striated
muscle energy production and metabolism, in part
through the regulation of mitochondrial localization
and function.
INTRODUCTION
Mitochondria are obligate endosymbionts that generate ATP
for cellular energy through oxidative phosphorylation and
play central roles in metabolism, calcium homeostasis, and
apoptosis (Parekh, 2003; Suen et al., 2008). They are often
distributed nonrandomly in differentiated cells like neurons and
muscle, presumably to provide energy to regions high in meta-
bolic demand. In neurons, mitochondria are enriched at syn-
apses (Hollenbeck and Saxton, 2005), whereas in mammalian
skeletal muscle, mitochondria are positioned in pairs near the348 Developmental Cell 22, 348–362, February 14, 2012 ª2012 ElsevI-bands (Vendelin et al., 2005). Motor proteins that move
along microtubules drive mitochondrial transport over long
distances (Hollenbeck and Saxton, 2005). However, the actin
cytoskeleton can facilitate short-range mitochondrial movement
and docking of mitochondria to specific sites (Boldogh and Pon,
2007; Pathak et al., 2010). In chicken sensory neuron cultures,
Nerve Growth Factor-conjugated beads promote mitochondrial
accumulation and docking by a mechanism dependent on
F-actin (Chada and Hollenbeck, 2004). These data raise the
possibility that growth factors may affect mitochondrial localiza-
tion in vivo.
The VAPs (VAMP/synaptobrevin-associated proteins) com-
prise a highly conserved protein family with an N-terminal MSP
(major sperm protein) domain, a coiled-coil motif, and trans-
membrane-spanning region anchored in endoplasmic reticulum
(ER) membranes. The 120 amino acid MSP domain is named
after C. elegans MSPs, which function as secreted ligands that
induce oocyte maturation and ovarian muscle contraction (Han
et al., 2010; Miller et al., 2001). MSPs also have an intracellular
cytoskeletal function, but this function is independent of actin
and myosin, depends upon MSP polymerization into filaments,
and is not conserved in VAPs (Bottino et al., 2002; Han et al.,
2010; Lev et al., 2008). VAPs have been implicated in diverse
processes, including regulation of lipid transport, ER mor-
phology, and membrane trafficking (Lev et al., 2008). In addition,
VAPs and MSPs have a conserved function as a secreted
signaling molecule (Tsuda et al., 2008). We have shown that
VAP MSP domains (vMSPs) are cleaved from the trans-
membrane domain and secreted into the extracellular environ-
ment, where they bind to Eph receptors (EphRs) and other
unidentified receptors (Miller et al., 2003; Tsuda et al., 2008).
The secretion mechanism appears to be unconventional and
cell type specific.
A P56S mutation in the human VAPB MSP domain causes
amyotrophic lateral sclerosis (ALS) and late-onset spinal
muscular atrophy (SMA), two neuropathies characterized by
progressive muscle atrophy and motor neuron degeneration
(Funke et al., 2010; Millecamps et al., 2010; Nishimura et al.,
2004). VAPP56S causes VAP ubiquitination, recruitment of wild-
type and mutant VAPs to cytoplasmic inclusions (Teuling et al.,ier Inc.
Figure 1. Neuronal VAPs Modulate Striated Muscle Mitochondrial Morphology in Drosophila and C. elegans
(A) Transmission electron micrographs of adult IFM (dorsal ventral) in wild-type control and mutant flies. Arrowheads indicate myofibrils and arrows indicate
mitochondria. DVAP indicates dvap null mutant and C164 > WTdVAP indicates wild-type dVAP expression using the neuronal GAL4 driver, C164 GAL4. Low
magnification bars, 1.0 mm; high magnification bars, 0.5 mm.
(B and C) C. elegans body wall muscle cell diagrams showing mitochondrial arrays (B) and basic myofilament structure (C).
(D) Muscle mitochondria tubules visualized using mitochondrial matrix-targeted GFP (mitoGFP) and dense bodies (small bumps running in parallel) visualized
using DIC imaging. Dense bodies occupy the center of the I-band. Quantification is shown in Table S1. Asterisks indicate nucleus. Bar, 5 mm.
(E) Mitochondrial networks in wild-type and mutant body wall muscle. Neuronal expression is driven with the unc-119 promoter and muscle expression is driven
with the myo-3 promoter. Asterisks indicate nucleus. Bars, 5 mm.
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(Tsuda et al., 2008). VAPB levels are reduced in sporadic ALS
patients, sod1 mutant mice, and ALS8 patient motor neurons
derived from induced pluripotent stems cells, suggesting that
VAPB plays a widespread role in pathogenesis (Anagnostou
et al., 2010; Mitne-Neto et al., 2011; Teuling et al., 2007).
Here, we present evidence that MSP domains comprise
a conserved ligand class that modulates mitochondrial localiza-
tion and morphology in muscle and oocytes. Neurons secrete
vMSPs to promote mitochondrial docking at actin-rich I-bands
of C. elegans striated muscle. vMSPs transduce signals through
muscle Roundabout and Lar-like receptors that modulate the
actin-related protein 2/3 (Arp2/3) complex. VAP loss causes
aberrant Lar receptor and Arp2/3 activity that displaces mito-
chondria from I-bands, influences the fission/fusion balance,
and decreases transmembrane potential. We propose that
neurons secrete vMSPs to promote mitochondrial localization
and function important for energy metabolism in muscles.DevelopmRESULTS
VAP Loss Causes Muscle Mitochondrial Defects in
Drosophila and C. elegans
We previously documented that neuronal overexpression of
dVAP, a Drosophila VAPB homolog (Pennetta et al., 2002),
caused myofibrillar defects in the indirect flight muscle (IFM)
of adult flies (Tsuda et al., 2008). This defect could be sup-
pressed by Eph receptor knockout, suggesting that neurons
secrete the dVAP MSP domain. The IFMs are massive and
provide most of the energy needed for flight. To test whether
VAP loss affects muscle, we examined the IFM in wild-type
and dvap null mutant flies using transmission electron micros-
copy (TEM). In wild-type adults, TEM shows that the mitochon-
dria are arranged in columns between the myofibrils (Figure 1A).
In contrast, most mitochondria in dvap null mutant muscle are
small and have abnormal cristae, whereas others are larger
and have vacuole-like structures (Figure 1A; 84% of theental Cell 22, 348–362, February 14, 2012 ª2012 Elsevier Inc. 349
Figure 2. Transmission Electron Micro-
graphs of Wild-Type and Mutant
C. elegans Muscle
(A–D) Adult body wall muscle cross-sections
are shown. Arrowheads point to mitochondria with
I-band localization, whereas arrows point to
mitochondria with abnormal localization. Light
blue color demarcates muscle boundary. Bar,
0.5 mm.
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VAPB and Mitochondriamitochondria lack lamellar cristae, whereas 7% are enlarged,
lack electron density, and are highly aberrant [n = 123]). The
myofibrils, on the other hand, appear similar to control myofi-
brils. Hence, dVAP loss causes severe mitochondrial mor-
phology defects in adult fly muscles.
Next, we examined adult C. elegans body wall muscle to test
whether the role of VAPs (vpr-1 in worms) is evolutionarily
conserved. Mitochondria were visualized in live muscle by ex-
pressing mitochondrial matrix-targeted GFP (mitoGFP) under
control of the myo-3 muscle promoter, as well as by feeding
worms the dyes MitoTracker CMXRos and Rhodamine 6g. In
wild-type adults, muscle mitochondria form largely unbranched
tubules within the belly (Figures 1B and 1C). 84.7% of these
tubules in mitoGFP transgenic worms form linear arrays that
are regularly spaced, correlating with the spacing between
I-bands (Figures 1C and 1D; Table S1, line 1 available online).
Indeed, the mitochondrial arrays overlap with the dense bodies,
which occupy the middle of the I-band and appear as small
bumps organized in the same orientation as the myofilaments
(Figure 1D). Identical results are observed with MitoTracker
CMXRos and Rhodamine 6g. Additional support for the associ-
ation of mitochondria with I-bands comes from muscle TEM
cross-sections (Figure 2A).
In contrast to wild-type, mitochondria in vpr-1(tm1411)
mutants are not arranged in parallel arrays and are rarely associ-
ated with dense bodies (Figures 1D and 1E; Table S1, lines 1
and 2). Three-dimensional microscopy indicates that mitochon-
dria form thin and highly branched tubular networks within
the muscle belly (Figure 1E). TEM cross-sections confirm that350 Developmental Cell 22, 348–362, February 14, 2012 ª2012 Elsevier Inc.mitochondrial tubules in vpr-1 mutant
muscle are smaller in diameter than
controls and mostly displaced from the
myofilaments (Figure 2B; Table S1, lines
1 and 2, p < 0.001). The muscle belly is
expanded, in part due to abnormal actin
branching (see below) and mitochondria
rarely localize to I-bands. Musclemyofila-
ments, ER, and motor neuron positions
in vpr-1 mutants appear similar to the
wild-type (Figure 2B; data not shown).
Moreover, vpr-1 mutants do not ex-
hibit abnormal muscle ER homeostasis
(S.M.H. and M.A.M., unpublished data).
We conclude that vpr-1 is required for
formation of tubular and largely un-
branched mitochondrial arrays posi-
tioned along the I-bands. Collectively,
these data indicate that VAP loss inDrosophila and C. elegans causes specific defects in muscle
mitochondrial morphology.
VAP Mutants Have Interconnected Mitochondrial
Networks
The mitochondrial tubules in vpr-1 mutant muscle appear more
fused than tubules in wild-type muscle (Figure 1E). RNAi of the
outer membrane fission mediator drp-1 and the inner membrane
fusion mediator EAT-3/OPA1 can be used to shift the fission/
fusion balance in mitochondrial networks (Kanazawa et al.,
2008; Labrousse et al., 1999). Shifting the balance toward fusion
in wild-type animals by drp-1 RNAi causes the formation of elon-
gated and branched networks similar to those in vpr-1 mutants,
except that the matrix often accumulates in large aggregates
(Figure 3A). drp-1 RNAi in vpr-1mutants also causes accumula-
tion of identical aggregates. Shifting the balance toward fission
in wild-type and vpr-1 mutant animals by eat-3/opa1 RNAi
causes mitochondrial fragmentation (Figure 3A). These data
suggest that muscle mitochondria in vpr-1 mutants have low
fission/fusion balance.
We tested whether or not the mitochondrial tubules in vpr-1
mutants are physically connected to each other, consistent
with their appearance in confocal axial scans. Fluorescence
loss in photobleaching (FLIP) can be used to assess connectivity
among muscle mitochondria. Our fluorescence recovery after
photobleaching experiments (data not shown) and a previous
study demonstrate that mitoGFP rapidly diffuses between
contiguous compartments (Labrousse et al., 1999). In FLIP ex-
periments, a mitochondrial tubule is repeatedly photobleached
Figure 3. vpr-1 Loss Influences Muscle Mitochondrial Connectivity and Function
(A) Genetic relationships between vpr-1 and the mitochondrial fission mediator drp-1 or the fusion mediator eat-3. Asterisks indicate nucleus. Bar, 5 mm.
(B) MitoGFP fluorescence loss in photobleaching of wild-type control and vpr-1mutant muscle. The red circle indicates the area of laser bleaching. Fluorescence
was measured throughout the field after each 5 s cycle. Intensities of numbered spots are shown in (C) and (D). Bar, 5 mm.
(C and D) Quantification of fluorescence intensities in indicated mitochondria (B) of control (C) and vpr-1 mutant (D) muscles.
(E) MitoTracker CMXRos staining of wild-type and vpr-1(tm1411) mutant muscle. Bar, 5 mm.
(F andG) Oxygen consumption rates of wild-type andmutant hermaphrodites. Consumption rates were normalized by protein content (F) or number of worms (G).
*p < 0.001. Error bars represent SD.
(H) ATP concentration in wild-type and mutant hermaphrodite extracts. *p < 0.001 compared to wild-type. Error bars represent SD.
(I) Paraquat sensitivity in wild-type and vpr-1(tm1411) hermaphrodites. Error bars represent SD.
Developmental Cell
VAPB and Mitochondriaevery 5 s followed by a scan of the surrounding area. Contiguous
mitochondria lose fluorescence during each cycle, as mitoGFP
diffuses into the bleached area. Thus, interconnected mitochon-Developmdrial networks will exhibit rapid reduction in fluorescence outside
of the bleached spot. To assess mitochondrial connectivity with
FLIP, we used conditions that stabilizemitochondria and preventental Cell 22, 348–362, February 14, 2012 ª2012 Elsevier Inc. 351
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VAPB and Mitochondriatheir mobility. FLIP in control muscles causes rapid fluorescence
loss in the targeted area, but the vast majority of surrounding
mitochondria retain their fluorescence, even after 48 cycles
(Figures 3B and 3C). In 5 of 11 experiments, a single neighboring
tubule lost fluorescence. The average bleached area in the 11
experiments was 7.8 mm2, indicating that individual tubules
have limited connectivity in wild-type muscle. In contrast to the
wild-type, FLIP in vpr-1 mutant muscles resulted in rapid loss
of fluorescence in the targeted area and numerous surrounding
mitochondrial tubules within 20 s of photobleaching initiation
(Figures 3B and 3D). The average bleached area in nine experi-
ments was 32.6 mm2 (p < 0.001 compared to the control). We
calculated that each vpr-1 mutant muscle contains between
20 and 25 contiguous subpopulations of mitochondria, whereas
each wild-type muscle contains more than 100 subpopulations
(based on an average muscle area of 800 mm2). Therefore, mito-
chondrial networks in vpr-1 mutant muscle exhibit increased
connectivity relative to networks in wild-type muscle. This in-
crease in connectivity may be due to an increase in fusion,
reduction in fission, or both.
Mitochondrial dynamics can be observed in live animals using
time-lapse fluorescence microscopy. Mitochondria in wild-type
muscle appear stably docked at I-bands (Movie S1). Shape
changes and fission gradually reduce tubule length over time
during imaging. In vpr-1 mutants, mitochondrial tubules ex-
hibit increased mobility (Movie S2) and occasionally form ring-
shaped structures that join other tubules or collapse (Figure S1A;
Movie S3). Tubules move at speeds between 0 and 2.0 mm/min,
although only a fraction of tubules are mobile under our condi-
tions. We noticed that fission sites in wild-type muscle are
different than sites in vpr-1mutant muscle. In the control, fission
primarily occurs within elongated tubules (29/29 fission events
from eight videos). However, fission rarely occurs within elon-
gated tubules in vpr-1 mutants (1/12 fission events from eight
videos) and instead occurs at connection sites between tubules
(Movie S4). We conclude that mitochondria in vpr-1mutants are
more mobile and have different fission sites relative tomitochon-
dria in wild-type muscle. Taken together, the results support the
model that VPR-1 influences the fission/fusion balance.
VAP Mutants Have Impaired Mitochondrial Function
The abnormal mitochondrial morphology in vpr-1mutants raises
the possibility that their function is impaired. To evaluate muscle
mitochondrial function, we used MitoTracker CMXRos, which
concentrates in the mitochondrial matrix depending on trans-
membrane potential (Pendergrass et al., 2004). MitoTracker
accumulation in vpr-1 mutant muscle mitochondria is reduced
compared to accumulation in controls (Figure 3E). We found
that drp-1 RNAi could increase MitoTracker accumulation,
suggesting that matrix aggregation caused by DRP-1 loss can
partially restore mitochondrial transmembrane potential in
vpr-1 mutants (Figure S1B). Importantly, this MitoTracker accu-
mulation defect can be fully suppressed (see below), indicating
that vpr-1 mutants are not deficient in dye uptake or muscle
transport.
Worms with reduced mitochondrial respiration should con-
sume less oxygen and generate less ATP. Indeed, vpr-1mutants
consume lessoxygen thancontrols,whether thedata arenormal-
ized to protein content (Figure 3F) or worm number (Figure 3G).352 Developmental Cell 22, 348–362, February 14, 2012 ª2012 ElsevATP concentration in 1-day-old adult vpr-1 mutants is signifi-
cantly reduced compared to adult controls (Figure 3H). We previ-
ously showed that sperm-derived MSPs promote reactive
oxygen species (ROS) production in oocytes (Yang et al., 2010).
vpr-1mutants are more resistant than the wild-type to paraquat,
which generates intracellular ROS that cause a concentration-
dependent toxicity depending on endogenous ROS levels
(Figure 3I). Hence, vpr-1 mutants have reduced ROS, which
could be due to decreased production or increased breakdown.
These independent metabolic assays support the hypothesis
that vpr-1mutants have altered mitochondrial function.
Inhibition of mitochondrial electron transport chain (ETC)
activity causes defects such as sluggish motility, reduced swim-
ming rate in liquid, prolonged defecation cycle, reduced brood
size, slow development, and larval arrest (Tsang and Lemire,
2003; Wong et al., 1995a). In particular, muscle-specific ETC
inhibition affects motility, brood size, and possibly defecation
and development rate (Durieux et al., 2011). Thus, vpr-1mutants
should exhibit some of these defects if their mitochondria have
reduced respiration, as indicated by the metabolic assays.
Indeed, vpr-1 null mutants exhibit sluggish motility, reduced
swimming rate (99.7 ± 9.4 thrashes/min for vpr-1(tm1411) versus
125.3 ± 11.8 thrashes/min for wild-type; p < 0.005), prolonged
defecation cycle (59.9 ± 7.2 s for vpr-1(tm1411) versus 55.0 ±
7.1 s for wild-type; p < 0.01), sterility, and slow development
(57.7 ± 3.9 hr for vpr-1(tm1411) versus 42 hr for wild-type;
p < 0.001). We conclude that vpr-1mutants have defects consis-
tent with abnormal mitochondrial function in muscle and
possibly other cell types.
Secreted Neuronal vMSPs Modulate Muscle
Mitochondrial Position and Morphology
Our previous studies showed that VAP MSP domains are
secreted in a cell type-specific fashion (Tsuda et al., 2008).
However, VAPs can also have cell autonomous functions. To
determine the site(s) where VAPs function, we first examined
Drosophila. Expressing dVAP in muscle of dvap null mutant flies
using theMHC-GAL4 driver causes 100% lethality and does not
rescue dvapmutant defects. In contrast, expressing dVAP using
neuronal drivers, including C164-GAL4 and Elav-GAL4, rescues
the lethality (Chai et al., 2008; Tsuda et al., 2008) and nearly
100% of muscle mitochondrial defects associated with dvap
loss (Figure 1A; data not shown). These data indicate that
dVAP functions in a cell nonautonomous fashion, consistent
with a signaling role.
Next, we examined the mechanism by which VPR-1 acts
on muscle in C. elegans. Transgenic GFP reporters driven by
upstream vpr-1 genomic sequence show broad expression in
adults, including the ventral nerve cord and body wall muscle
(Figure S2), similar to Drosophila dVAP. However, vpr-1 expres-
sion in muscles using the myo-3 promoter or intestine using the
ges-1 promoter does not affect muscle mitochondrial shape or
distribution in the mutants (Figure 1E; Figure S1C). In contrast,
vpr-1 expression in neurons with the unc-119 pan-neuronal
promoter rescues mitochondrial morphology, distribution, and
I-band position (Figures 1E) in 30%–40% of muscles, while
most remaining muscles exhibit improved phenotypes. The
incomplete rescue may be due to transgene expression
mosaicism, overexpression, or missing untranslated regulatoryier Inc.
Figure 4. VAP Cleavage and Secretion in C. elegans Neurons
(A) Diagrams of the mCherry::VPR-1::GFP fusion protein driven specifically in neurons. Scissors show region of cleavage. cc, coiled-coil domain.
(B) Fusion protein expression in nerve cord motor neurons. Arrowheads indicate examples of mCherry/MSP-containing complexes that lack GFP-containing
sequences. Bar, 5 mm.
(C) Fusion protein localization outside of neuronal cell bodies.
(D) Fusion protein localization in the vulva region. VC4 and VC5 motor neuron cell bodies (yellow arrows) are in the background (behind the focal plane). Inset
shows the HSN motor neuron cell body. Longer mCherry exposure times show mCherry colocalization with GFP in the cytoplasm. The vulva lip exhibits
nonspecific autofluorescence seen in nontransgenic controls (white arrows).
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of mitochondrial defects and neuron-specific VPR-1 inhibition
causes mitochondrial defects in nearly all muscle (data not
shown and see below). We conclude that VAPs are required in
neurons to control muscle mitochondrial position and shape.
The above data are consistent with neurons secreting
vMSP domains to regulate muscle mitochondria. To further
test this model, we inhibited neuronal vMSP secretion in wild-
type worms. The VAPP56S mutation acts as a dominant negative,
sequestering wild-type VAP in neuronal aggregates (Ratnaparkhi
et al., 2008; Teuling et al., 2007) and preventing secretion of the
wild-type protein (Tsuda et al., 2008). Neuronal VPR-1P56S over-
expression causes muscle mitochondria to form thin, branched,
and abnormally distributed networks within the muscle belly,
similar to vpr-1 null mutants (Figure 1E).Whenwe overexpressed
neuronal VPR-1P56S in vpr-1 null mutants, muscle mitochondria
were identical to those seen in nontransgenic vpr-1 mutant
controls. These data confirm that VPR-1P56S acts as a dominant
negative and support the model that neurons secrete vMSPs to
regulate muscle mitochondria.
C. elegans, Drosophila, and mammalian VAPs are cleaved
between the MSP domain and the transmembrane domain
(Gkogkas et al., 2011; Tsuda et al., 2008). Previously, we docu-
mented vMSP secretion in Drosophila wing disc cells by ex-
pressing a dVAP fusion protein with distinct N-terminal and
C-terminal tags (Tsuda et al., 2008). Only the N-terminal tag con-
taining the MSP domain was secreted. We used a similar
strategy to test whether C. elegans neurons secrete the VPR-1
MSP domain. mCherry was fused to the N-terminus of VPR-1
and GFP to the C terminus and this mCherry::VPR-1::GFP fusionDevelopmprotein was expressed in neurons using the unc-119 promoter
(Figure 4A). While partial colocalization of mCherry and GFP
was observed in motor neuron cell bodies (and other neuron
bodies), mCherry was observed within axons and in the extracel-
lular environment (Figures 4B–4D). GFP does not colocalize with
most axonal mCherry, nor does it colocalize with extracellular
mCherry, indicating that the VPR-1 fusion protein is cleaved.
Secreted mCherry/MSP fragments were observed at the body
wall and vulval muscles (Figures 4C and 4D). mCherry also accu-
mulated in the coelomocytes, mesodermal cells that nonspecif-
ically endocytose fluid, and secreted molecules within the body
cavity (data not shown) (Fares and Greenwald, 2001). Taken
together, these results provide strong evidence that neurons
secrete vMSPs.
An MSP Receptor Screen Identifies SAX-3 Robo
and CLR-1 Lar Receptors
An important prediction based on above data is that secreted
vMSPs regulate a muscle receptor pathway(s) that transduces
signals tomitochondria. vMSPs bind to EphRs and other uniden-
tified receptors (Miller et al., 2003; Tsuda et al., 2008). However,
EphR loss in C. elegans or Drosophila does not influence muscle
mitochondria or mitochondria-related phenotypes (data not
shown), suggesting that an unknown receptor(s) mediates this
signaling mechanism. We previously developed an MSP re-
ceptor identification assay based on the ability of recombinant
MSP domains conjugated to fluorescein (MSP-FITC) to specifi-
cally bind to receptors expressed in oocytes (Miller et al.,
2003; Figures S3A and S3B). In the worm gonad, sperm secrete
MSPs to induce oocyte maturation (Figure 5A), which involvesental Cell 22, 348–362, February 14, 2012 ª2012 Elsevier Inc. 353
Figure 5. An MSP Receptor Screen Identifies SAX-3 Robo and CLR-1 Lar-Like Receptors
(A) Diagram of the C. elegans adult gonad. Mitochondrial morphology and MSP domain binding were quantified in oocytes colored green (B–D and Figure S4).
DTC, distal tip cell; Sp, spermatheca.
(B) Quantification of ring-shaped mitochondria per mm2 oocyte area in the presence and absence of extracellular MSP domains introduced by mating and
microinjection. MSP domains were injected through the vulva into the reproductive tract of unmated females lacking sperm. See Figures S4A–S4D for repre-
sentative pictures of oocyte mitochondria. *p < 0.001 compared to unmated female controls. Error bars represent SEM.
(C) Two hundred nanomolar MSP-FITC binding to oocyte plasma membranes. In the compete panels, a 20-fold molar excess of unlabelled MSP or hVAP MSP
was added before the assay. Quantitative data is shown in (D). Proximal is to the right, as shown in (A) (green). Bar, 20 mm.
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VAPB and Mitochondriametabolic changes (Han et al., 2010; Yang et al., 2010). Under
conditions where all MSP receptor sites are occupied, MSP-
FITC binding to oocytes is reduced by 35% when the VAB-1
EphR is absent (Miller et al., 2003). The remaining binding is
due to unidentified MSP domain receptors. Sperm-derived
MSPs and VAP MSP domains bind to identical receptors ex-
pressed in oocytes (Miller et al., 2003; Tsuda et al., 2008). We
hypothesized that both oocytes and muscle express MSP
domain receptors that transduce signals to mitochondria. Sup-
port for this hypothesis comes from examining the effects of
extracellular MSP addition to oocyte mitochondria. Microinject-
ing MSPs and human vMSPs into the extracellular spaces
of spermless reproductive tracts induces a rapid transition
(<15 min) in oocyte mitochondria from ring-shaped to branched,
tubular forms (Figures 5A and 5B; Figures S4A–S4D). These
shape changes, as well asMSP-inducedmitochondrial transport
into growing oocytes (Govindan et al., 2009; Wolke et al., 2007),
are dependent on drp-1 (Figures S4E and S4F). Identical shape
changes in oocyte mitochondria occur when sperm presence
is manipulated through mating (Figure 5B; Figures S4B–S4D).
Thus, oocytes likely express MSP receptors that rapidly regulate
mitochondrial shape.
To identify MSP domain receptors important for mitochondria,
we compared genome-wide DNA microarray data sets of adult
hermaphrodites undergoing oogenesis to those undergoing
spermatogenesis (Reinke et al., 2004). MSPs bind to oocyte
plasmamembranes, but not to sperm plasmamembranes (Miller
et al., 2003). From the top 3000 oogenesis/spermatogenesis-
enriched genes, we identified 40 genes that encode cell surface
receptors (Table S2). These genes are not specifically expressed
in oocytes; many are also expressed in neurons and muscle. We
screened RNAi clones corresponding to the 40 predicted recep-
tors to identify clones that cause reduced MSP-FITC binding to
oocytes and mitochondrial shape or positioning defects in
oocytes and muscle (Table S2). The only RNAi clones that
affected both MSP binding and muscle mitochondria corre-
sponded to the SAX-3 Roundabout (Robo) and CLR-1 Lar-like
(Lar) receptors (Figures 5C and 5D; Table S2; Kokel et al.,
1998; Zallen et al., 1998). Analysis of clr-1 and sax-3 mutants
confirmed that both receptors are required for MSP-FITC
binding and muscle mitochondrial morphology (see below).
Previous studies have shown that SAX-3 Robo and CLR-1 Lar
are expressed in oocytes, motor neurons, and body wall muscle
(Chang et al., 2004; Kohara, 2001; Zallen et al., 1998).
SAX-3 or CLR-1 loss causes a significant reduction in MSP-
FITC binding to oocytes, similar to loss of the MSP/ephrin
receptor VAB-1 (Figures 5C and 5D). To test whether CLR-1
Lar or SAX-3 Robo expression is sufficient to promote MSP
binding, we expressed these receptors alone and in combination
in cultured HEK293 cells (Figures 5E–5G). Expressing the VAB-1(D) Quantitative MSP-FITC binding data for control and selected RNAi clones (
represent SEM.
(E) Two hundred nanomolar human VAP MSP-FITC was incubated with control t
times, and mounted for microscopy. vMSP-FITC was found at the cell surface a
excess of unlabelled MSP was added before the assay. Bar, 50 mm.
(F) Quantification of human VAP MSP-FITC fluorescence. *p < 0.001 compare
represent SD.
(G) Quantification of MSP-FITC fluorescence. *p < 0.001 compared to control. N
DevelopmEphR in cultured cells confers increased MSP-FITC cell surface
binding and rapid internalization in live cells (Miller et al., 2003).
We found that CLR-1 Lar expression resulted in the same signif-
icantly increased level of MSP-FITC and vMSP-FITC binding as
the VAB-1 EphR positive control, whereas Robo expression
resulted in a weak increase relative to the negative control (Fig-
ures 5E–5G). However, expressing both SAX-3 Robo and CLR-1
Lar together caused a synergistic increase in MSP and vMSP
binding, which could be inhibited by incubating cells with an
excess of unlabelled MSP (Figures 5E–5G). These data support
the model that Robo and Lar function together to promote
vMSP binding. Consistent with this idea, SAX-3 and CLR-1
loss synergistically affects human vMSP binding to C. elegans
oocytes (Figures S3C and S3D). In summary, our screen identi-
fied SAX-3 Robo and CLR-1 Lar, perhaps acting via a receptor
complex, as candidates for mediating VAP signaling to muscle
mitochondria.
SAX-3 Robo and CLR-1 Lar Function in Muscle
to Influence Mitochondria
To specifically evaluate muscle mitochondria in sax-3 Robo
and clr-1 Lar mutants, we generated myo-3p::mitoGFP trans-
genic lines. sax-3(ky123) mutants have incompletely penetrant
and variably expressed mitochondrial defects [63.7% of sax-
3(ky123) muscles affected (n = 55) versus 100% for vpr-1
mutants [n > 400]). The affected muscles have mitochondrial
networks nearly identical to vpr-1mutants, including abnormally
positioned elongated mitochondria with excess branching (Fig-
ure 6A; Table S1, lines 1–3). TEM cross-sections of sax-3mutant
muscle show that mitochondria are smaller in diameter than
controls and mostly displaced from the I-bands, similar to
vpr-1 mutants (Figures 2A–2C). However, the muscle belly is
less swollen than vpr-1mutants and not all sax-3mutantmuscles
are affected, consistent with the presence of a second vMSP
receptor. The sax-3(ky123) mutant defects were rescued with
a fosmid containing the sax-3 genomic locus, indicating that
the defects are due to loss of SAX-3 Robo (Figure 6A). Temper-
ature shift experiments using the sax-3(ky200)ts hypomorphic
temperature sensitive (ts) allele indicate that sax-3 is required
postembryonically (Figure 6A). We also tested the gene encod-
ing the Slit ligand for SAX-3 Robo and did not detect mitochon-
drial defects in slt-1(eh15) null mutants (Figure 6A). As slt-1 is the
only Slit homolog present in C. elegans (Hao et al., 2001), SAX-3
does not require Slits for regulating muscle mitochondrial mor-
phology. Therefore, sax-3Robo influencesmusclemitochondrial
shape and positioning independent of Slit.
Next, we evaluated metabolic status in sax-3 Robo mutants.
MitoTracker CMXRos staining indicated that sax-3(ky123)
mutants have a variably expressed transmembrane potential
defect (Figure 6B) where the more severe cases resemblen is to the right of error bars). *p < 0.001 compared to wild-type. Error bars
ransfected and receptor transfected HEK293T cells for 30 min, washed three
nd in intracellular vesicles of live cells. In the compete panel, a 20-fold molar
d to control. Number of cells measured is shown below error bars, which
umber of cells measured is shown below error bars, which represent SD.
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Figure 6. sax-3 Robo and clr-1 Lar-like Receptor Mutant Phenotypes
(A) Muscle mitochondrial networks in wild-type control and mutant hermaphrodites. Fosmid indicates expression of a transgene containing the sax-3 genomic
locus. sax-3(ky200)ts mutants were shifted to the nonpermissive temperature (25C) at the L1 stage and scored in 1 day adults. clr-1(e1745)ts mutants were
shifted to the nonpermissive temperature (25C) in young adults and scored 12 hr later. Asterisks indicate nucleus. Bar, 5 mm.
(B) MitoTracker CMXRos staining of live muscles. Asterisks indicate nucleus. Bar, 5 mm.
(C) Oxygen consumption rates of wild-type and sax-3 mutant 1-day-old adults. Consumption rates were normalized to protein content (left) or worm number
(right). *p < 0.005 compared to wild-type. Error bars represent SD.
(D) ATP concentration in wild-type and mutant hermaphrodite extracts. *p < 0.001 compared to wild-type. Error bars represent SD.
(E) Paraquat sensitivity in wild-type and sax-3(ky123) hermaphrodites. Error bars represent SD.
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controls, but contained less total protein, so the interpretation
depends on the normalization method (Figure 6C). Compared
to wild-type controls, sax-3 mutants had reduced ATP concen-
tration (Figure 6D), increased resistance to paraquat (Figure 6E),
and slower growth [53.8 ± 3.6 hr for sax-3(ky123) versus 42 hr for
wild-type; p < 0.001]. These data indicate that sax-3 mutants
have metabolic or mitochondrial defects that are similar to vpr-
1 mutants, but most defects are less severe or occur with
reduced frequency.
sax-3 Robo is expressed in motor neurons and body wall
muscle (Chang et al., 2004; Kohara, 2001; Zallen et al., 1998).
To test whether sax-3 functions in muscle, we conducted two
experiments. In the first, we expressed SAX-3 specifically in
muscle of sax-3(ky123) mutants using the myo-3 promoter.356 Developmental Cell 22, 348–362, February 14, 2012 ª2012 ElsevMuscle-specific SAX-3 expression strongly rescued the sax-
3(ky123) muscle mitochondrial defects (Figure 7A; rescue
observed in 27/31 transgenic worms). Next, we specifically
depleted SAX-3 in body wall muscle of wild-type worms using
an RNAi mosaic strategy (Durieux et al., 2011; Esposito et al.,
2007). sid-1 mutants are defective for systemic RNAi, yet
undergo cell autonomous RNAi normally (Winston et al., 2002).
We specifically expressed sax-3 sense and antisense RNAs
(creating dsRNA) in sid-1(pk3321) muscle and examined their
mitochondria. Muscle-specific sax-3RNAi causedmitochondrial
defects nearly identical to those seen in sax-3 mutants (Fig-
ure 7A). These results indicate that sax-3 functions cell autono-
mously in body wall muscle to influence mitochondria.
Our RNAi screen also identified the CLR-1 Lar receptor
as a muscle mitochondrial regulator. In clr-1 RNAi andier Inc.
Figure 7. sax-3 Robo and clr-1 Lar Site of
Action and Signaling Hierarchy
(A) Muscle mitochondrial networks in wild-type
control and mutant hermaphrodites. The myo-3
promoter was used to drive sax-3 cDNA, sax-3
antisense/sense RNAi (), or clr-1 antisense/
sense RNAi () expression specifically in bodywall
muscle. sid-1(pk3321) mutants are defective for
systemic RNAi, but cell autonomous RNAi occurs
normally. clr-1(e1745)ts; sax-3(ky123) mutants
were scored at the nonpermissive temperature.
Unlike mitochondria in vpr-1(tm1411); clr-1 RNAi
mutants, mitochondria in clr-1(e1745)ts; sax-
3(ky123) mutants fail to elongate on the I-bands.
Asterisks indicate nucleus. Bar, 5 mm.
(B) MitoTracker CMXRos staining of live muscles.
Asterisks indicate nucleus. Bar, 5 mm.
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VAPB and Mitochondriaclr-1(e1745)ts mutant adults, most mitochondria are positioned
at the I-bands, but tubule length is much shorter than in the
wild-type (Figure 6A; Table S1, lines 1 and 4). Despite the
abnormal appearance of mitochondria, MitoTracker CMXRos
staining did not show decreased transmembrane potential
(Figure 6B). clr-1 is an essential gene required in hypodermal
cells for fluid balance and the e1745 allele is temperature
sensitive (Huang and Stern, 2004; Kokel et al., 1998). We con-
ducted temperature shift experiments to assess the temporal
requirement of clr-1 function. At the permissive temperature,
clr-1(e1745)ts adult muscles contain mostly tubular mitochon-
dria similar to the wild-type. When young adults were shifted
to the restrictive temperature for 12 hr, globular mitochondria
were observed similar to clr-1 RNAi animals (Figure 6A). These
results demonstrate that CLR-1 Lar is required in adults to
maintain mitochondrial elongation on the I-bands. To test
whether clr-1 functions in muscle, we specifically depleted
clr-1 in body wall muscle using the sid-1 mutant RNAi mosaic
strategy. Muscle-specific CLR-1 depletion caused the same
mitochondrial defects as those seen in clr-1 RNAi and
clr-1(e1745) mutants (Figure 7A). In contrast, hypodermis-
specific clr-1 RNAi caused fluid accumulation, but not muscle
mitochondrial defects (data not shown). Taken together, the
data indicate that SAX-3 Robo and CLR-1 Lar function in
muscle to influence mitochondria.
VPR-1 and SAX-3 Robo Antagonize CLR-1 Lar Signaling
Our data indicate that SAX-3 Robo and CLR-1 Lar function in
muscle, yet their mutant phenotypes are clearly different (Fig-Developmental Cell 22, 348–362,ure 6A). The sax-3 mutant mitochondrial
defects are nearly identical to the vpr-1
mutant defects. To examine the signaling
hierarchy between vpr-1 and sax-3, we
compared single and double null mutant
strains. TEMs show that mitochondrial
shape, including cross-sectional area,
and positions in the double mutants are
identical to single null vpr-1 mutants
(Table S1, lines 2 and 5, p > 0.1; data
not shown). In addition, ATP concentra-tion in vpr-1(tm1411); sax-3(ky123) double mutants is not signif-
icantly different than sax-3(ky123) null mutants (Figure 6D).
Unfortunately, we were unable to generate mitoGFP transgenic
lines in the double mutants. Taken together with the binding
data, the results support the model that vMSPs positively regu-
late SAX-3 Robo.
Robo receptors antagonize Lar receptor signaling during
C. elegans and Drosophila growth cone guidance decisions
(Chang et al., 2004; Sun et al., 2000). Consistent with this rela-
tionship, the globular mitochondrial morphology in clr-1 Lar
mutants contrasts with the elongated morphology in VAP and
Robo mutants (Figures 1E and 6A). To examine the signaling
hierarchy, we compared vpr-1(tm1411); clr-1 RNAi mutants to
vpr-1(tm1441) mutants using the mitoGFP marker. clr-1 loss
strongly suppresses the muscle mitochondrial defects of vpr-1
mutants (Figure 7A; Table S1, lines 6 and 2) and muscle mito-
chondria in vpr-1(tm1411); clr-1 RNAi mutants are similar in
morphology and distribution to mitochondria in wild-type
hermaphrodites. Importantly, they are also positioned at muscle
I-bands (Table S1, line 6). MitoTracker CMXRos staining and
time-lapse imaging indicate that clr-1 loss suppresses the mito-
chondrial transmembrane potential and mobility defects of vpr-1
mutants (Figure 7B and data not shown). Thus, muscle mito-
chondria in vpr-1(tm1411); clr-1RNAi animals are largely normal.
This important result indicates that excess CLR-1 activity specif-
ically causes the vpr-1 mutant muscle mitochondrial defects.
Hence, VPR-1 antagonizes Lar signaling in muscle. Moreover,
a redundant mechanism must exist that positions mitochondria
in the absence of VPR-1 and CLR-1.February 14, 2012 ª2012 Elsevier Inc. 357
Figure 8. VAP Regulation of Arp2/3
Complex Activity and Working Model
(A) Filamentous actin distribution in wild-type and
vpr-1 mutant muscle, observed using muscle-
specific expression of the moesin actin binding
domain fused to GFP. Deconvolved images from
axial scans are shown. Belly panels are shownwith
distances beneath the sarcomere or myofila-
ments. Asterisks indicate nucleus. Bar, 5 mm.
(B) Muscle mitochondrial networks in wild-type
control and mutant/RNAi hermaphrodites. Aster-
isks indicate nucleus. Bar, 5 mm.
(C) Working model. See text for details.
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antagonize CLR-1 Lar signaling. To further test this model, we
generated clr-1(e1745)ts; sax-3(ky123) double mutants that
express mitoGFP. The mitochondrial branching and elongation
defects caused by sax-3 loss are suppressed in the double
mutant adults (Figure 7A). Furthermore, mitochondria in the
double mutants localize correctly to the I-bands. Therefore,
VPR-1 and SAX-3 Robo antagonize CLR-1 Lar signaling in
muscle to position mitochondria at I-bands. The simplest inter-
pretation is that SAX-3 Robo facilitates vMSP binding to CLR-1
Lar or SAX-3/CLR-1 complexes.
VAP/Robo/Lar Signaling Modulates the Arp2/3 Complex
Robo and Lar-like growth cone guidance receptors regulate the
actin cytoskeleton, which can influence mitochondrial localiza-
tion, either through direct interactions with F-actin or myosin358 Developmental Cell 22, 348–362, February 14, 2012 ª2012 Elsevier Inc.motors (Boldogh and Pon, 2007; Pathak
et al., 2010). To examine actin distribution
in body wall muscle, we expressed the
filamentous actin binding domain of moe-
sin fused to GFP (Figure 8A). In wild-type
muscle, actin was observed in parallel
arrays comprising the thin filaments, an I-
band component. Little filamentous actin
was observed in the muscle belly. While
no difference in actin was observed in
the sarcomeres of wild-type and vpr-1
mutant muscle, the latter had extensive
actin networks within the muscle belly
(Figure 8A). These ectopic actin networks
occupy the same position as mitochon-
dria, suggesting that their locations are
mechanistically linked. Consistent with
this idea, RNAi of genes encoding regula-
tors of the actin cytoskeleton, including
known downstream mediators of Robo
and Lar receptor signaling, caused
muscle mitochondrial defects (Figure S5).
The Arp2/3 complex promotes actin
nucleation and branching. Given the
branched filament networks in vpr-1
mutant muscle bellies, we hypothesized
that aberrant Arp2/3 activity in the belly
displaces mitochondria from I-bands,contributing to the mitochondrial defects. To test this hypoth-
esis, we used RNAi to deplete Arp2/3 complex components in
vpr-1 mutants. arx-2/arp2, arx-3/arp3, or arx-5/arp5 RNAi
suppresses the mitochondrial morphology and distribution
defects of vpr-1 mutants (Figure 8B). mitoGFP imaging and
TEMs of vpr-1(tm1411); arx-2 RNAi muscle indicate that large
mitochondria correctly localize to I-bands (Figure 2D; Table S1,
lines 2 and 7). Hence, aberrant Arp2/3 activity causes the VAP
mutant mitochondrial defects. The Arp2/3 and CLR-1 Lar
suppression data provide unequivocal evidence that these mito-
chondrial defects are specific and regulatory in nature. Finally,
Arp2/3 inactivation in wild-type muscle causes mitochondrial
morphology similar to those seen following Lar inactivation (Fig-
ure 8B; Table S1, lines 8 and 4). These data support the model
that vMSP/Robo/Lar signalingmodulates Arp2/3 activity to posi-
tion mitochondria at I-bands.
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EphR, Robo, and Lar-like receptors are called growth cone
guidance receptors because of their established roles in regu-
lating the actin cytoskeleton during nervous system develop-
ment. However, these receptors are also expressed after guid-
ance decisions are made, particularly in the adult central
nervous system and muscles (Longo et al., 1993; Zabolotny
et al., 2001; Zhang and Goldstein, 1991). Here, we show that
Robo and Lar-like receptor pathways act in adults to modulate
mitochondrial localization and morphology. Our results and
those from previous studies support the following model (Fig-
ure 8C). VAP MSP domains are cleaved in the neuron
cytoplasm and secreted into the external environment. vMSP
interactions with Robo and Lar receptors downregulate Lar
signaling to the Arp2/3 complex in muscle, stabilizing mito-
chondria at the I-bands. In VAP mutants, aberrant Lar and
Arp2/3 activity causes ectopic actin filaments in the muscle
belly that displace mitochondria from the I-bands, promote
mitochondrial mobility, elongation, and branching, and inhibit
energy metabolism. We propose that vMSPs restrict Arp2/3
activity to the I-bands, thereby influencing mitochondrial
morphology and fission/fusion balance. This neuron-governed
mechanism may regulate energy metabolism in response to
environmental, nutritional, or developmental cues. Evidence
for the model and implications for neurodegenerative diseases
are discussed below.
We show that VAPs and sperm-derived MSPs comprise an
evolutionarily conserved ligand class that promotes mitochon-
drial localization andmorphology. VAP, Robo, and Lar homologs
are present in sponges, animals without neurons and muscles,
suggesting that their role in regulating mitochondria is ancestral
to their growth cone guidance function (Srivastava et al., 2010).
Themechanism by which vMSPs regulate mitochondria appears
similar to the mechanism by which Slit repels migrating axons
(Chang et al., 2004; Sun et al., 2000). During nervous system
development, Slit binding to Robo downregulates Lar receptor
signaling that promotes migration. Therefore, Robo acts
upstream of Lar. We show that Robo is required for vMSP
signaling upstream of Lar. The simplest interpretation of our
genetic and binding data is that Robo facilitates vMSP binding
to Lar or Robo/Lar complexes, downregulating Lar signaling.
However, determining the extent to which high affinity vMSP
interactions depend upon receptor complex formation will
require further investigation. Given that EphR, Robo, and Lar
receptors are broadly expressed throughout the nervous
system, it is possible that vMSPs influence mitochondria in
neurons. dVAP regulates the presynaptic microtubule cytoskel-
eton (Pennetta et al., 2002), which controls mitochondrial trans-
port along axons (Hollenbeck and Saxton, 2005). Therefore,
neurons may secrete factors like VAPB that regulate mitochon-
dria in muscles and neurons.
The actin cytoskeleton regulates mitochondrial position in
C. elegans muscle, cultured Drosophila and chick neurons,
cultured mammalian cells, and yeast (Boldogh and Pon,
2007; Chada and Hollenbeck, 2004; Pathak et al., 2010; Quin-
tero et al., 2009; Starr and Han, 2002). The worm ANC-1
protein is thought to couple actin to mitochondria and anc-1
mutants have globular muscle mitochondrial morphologyDevelopmsimilar to arx-2 RNAi animals (Starr and Han, 2002). We show
that vMSPs promote mitochondrial docking at muscle I-bands,
actin-enriched sites containing structures analogous to focal
adhesions (Lecroisey et al., 2007). CLR-1 Lar and Arp2/3 are
required for maintenance or elongation of mitochondrial
tubules along I-bands, a process that may facilitate (and/or
require) fusion. In vpr-1 mutants, mitochondria mislocalize to
the muscle belly along with ectopic actin filaments and form
thin elongated branches with increased mobility, increased
fusion/fission balance, and reduced transmembrane potential.
Lar or Arp2/3 inactivation suppresses these defects, revealing
an unexpected role for the actin cytoskeleton in modulating
multiple aspects of mitochondrial biology. Whether Arp2/3
regulates mitochondria directly or indirectly through positioning
or docking effects is not clear. The actin cytoskeleton has been
shown to influence mitochondrial fission in cultured cells
(De Vos et al., 2005; Pathak et al., 2010). vMSP signals are
likely regulatory in nature, as a parallel mechanism promotes
mitochondrial positioning in the absence of VAP and Arp2/3
function.
Defects in skeletal muscle mitochondria have been impli-
cated in the pathology of ALS (Dupuis et al., 2004; Zhou
et al., 2010). In mutant sod1 transgenic mice, the SOD1 protein
aberrantly accumulates in mitochondria (Wong et al., 1995b;
Kong and Xu, 1998) and causes skeletal muscle mitochondrial
dysfunction that is initiated at the neuromuscular junction (Zhou
et al., 2010). Subsarcolemmal aggregates of abnormal mito-
chondria with low transmembrane potential are found in skel-
etal muscle of these mice well before the onset of the disease
(Zhou et al., 2010). ALS patients with a SOD1 mutation also
show a muscle mitochondrial oxidative defect (Corti et al.,
2009) and sporadic ALS patients have been documented with
muscle mitochondrial respiratory chain dysfunction (Crugnola
et al., 2010). Defects in muscle mitochondria may therefore
contribute as a primary cause in ALS pathogenesis. Indeed,
uncoupling electron transport from ATP synthesis in muscle
mitochondria by overexpressing uncoupling protein 1 is suffi-
cient to initiate motor neuron degeneration (Dupuis et al.,
2009).
Our results support the hypothesis that secreted vMSPs
modulate mitochondrial position through growth cone guidance
receptor pathways. It seems likely that this signaling mechanism
plays a role in ALS pathogenesis. The VAPBP56Smutation inhibits
wild-type andmutantMSP domain secretion (Tsuda et al., 2008).
Reducing vMSP secretion might cause abnormal mitochondrial
localization, morphology, and function in ALS8 patients. Consis-
tent with this model, low VAP levels in sporadic ALS patients and
mouse sod1 models correlate with widespread mitochondrial
abnormalities (Anagnostou et al., 2010; Dupuis et al., 2004,
2008; Teuling et al., 2007; Wong et al., 1995b). Moreover, anal-
yses of data from whole-genome associated studies have
discovered that single nucleotide polymorphisms within genes
mediating growth cone guidance, including Robo, Lar, and
Cdc42 are associated with susceptibility, survival, or onset of
ALS (Lesnick et al., 2008). In addition, the discovery that growth
cone guidance pathways influence mitochondria may have
implications for other neurodegenerative diseases, such as
spinal muscular atrophy and Parkinson’s disease (Lesnick
et al., 2007).ental Cell 22, 348–362, February 14, 2012 ª2012 Elsevier Inc. 359
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Genetics, RNAi, and Plasmids
Bristol N2 is the wild-type C. elegans strain. Worms were maintained on NGM
plates with NA22 bacteria at 20C except where indicated otherwise. Strain
construction and marker scoring were performed as previously described
using PCR and phenotypic analyses (Miller et al., 2003; Tsuda et al., 2008).
The fog-2(q71) mutation was used to generate male/female strains. RNAi
was performed by the feeding method using HT115 bacterial strains (Kamath
et al., 2003). Positive cloneswere sequenced for confirmation. See the Supple-
mental Experimental Procedures for additional information.
Staining, Microinjection, and Microscopy
Mitochondria were labeled using MitoTracker CMXRos, Rhodamine 6g, and
mito::GFP, which targets the matrix. For MitoTracker CMXRos and Rhoda-
mine 6g staining, dyes were added to seeded NGM plates (Labrousse
et al., 1999). Imaging was done without anesthetics on dried 2% agarose
pads immediately after mounting. Anesthetics can cause mitochondrial frag-
mentation. Images were taken using a motorized Zeiss Axioskop 2 with MRM
Axiocam Hi-Res digital camera and Perkin Elmer Spinning Disc Nikon
TE2000 microscope equipped with an EMCCD C9100-50 camera operated
by Velocity 5.3 software. Purified recombinant MSP domains were microin-
jected into the gonad using a Zeiss Axiovert 200 microscope. Injected
animals were mounted for direct observation after a 15 min to 1 hr recovery
period.
Transgenics
To generate transgenic C. elegans, plasmids (60 ng/ml) were mixed with pRF4
[rol-6] (60 ng/ml) ormyo-3p::mito::GFP (60 ng/ml) and injected into young adult
hermaphrodite gonads. The myo-3p::mito::GFP plasmid was generously
provided by Dr. van der Bliek. Transgenic lines were selected based on the
roller phenotype or GFP expression. Multiple independent transgenic lines
were analyzed. Two vpr-1(tm1411)/hT2; unc-119p::vpr-1 transgenic lines
were integrated by gamma irradiation.
Fluorescence Loss in Photobleaching
Fluorescence loss in photobleaching (FLIP) was achieved with a Perkin Elmer
Spinning Disc Nikon TE2000 microscope programmed to cycle between
bleaching and scanning every 5 s for 4min. The fluorescence intensities of indi-
cated areas were analyzed in Volocity software (Perkin Elmer, UK). Animals
were immobilized on dried 2% agarose pads under conditions that prevent
animal and mitochondrial mobility (i.e., one to three animals per pad). Only
muscles with immobile mitochondria were analyzed.
MSP Binding Assays
MSP-FITC and vMSP-FITC binding assays were conducted as previously
described (Miller et al., 2003; Tsuda et al., 2008). Briefly, HEK293T cells
were cultured on coverslips in 6-well plates and cells (50% confluence)
were transiently transfected with 2 mg of VAB-1, 3xFLAG::SAX-3, CLR-
1::V5, or pcDNA3.2 control plasmids (Miller et al., 2003) using FuGENE HD
transfection reagent, according to the manufacturer’s instructions (Promega,
U.S.A). The 3 3 FLAG::SAX-3 construct was generously provided by Dr. Joe
Culotti. The CLR-1::V5 construct contained the CLR-1 extracellular and
transmembrane domains, but not the phosphatase domains. After 24 hr, cells
were incubated with MSP-FITC or vMSP-FITC for 30 min at 23C and
washed three times in 50 ml PBS. Transfected cells were preincubated
with a 25-fold molar excess of unlabelled MSP to evaluate specific binding.
Fluorescence was measured from linear range exposures using Axiovision
software.
Metabolic Assays
Resistance to paraquat (Ultra Scientific, USA), ATP concentration measure-
ment, oxygen consumption, and MitoTracker CMXRos staining methods are
described in Supplemental Experimental Procedures. Oxygen consumption
was measured at constant temperature (20C) using the oxygraph system
(Hansatech, UK).360 Developmental Cell 22, 348–362, February 14, 2012 ª2012 ElsevTransmission Electron Microscopy
TEM was performed as previously described (Tsuda et al., 2008; Whitten and
Miller, 2007). Care was taken to ensure that fixation occurred rapidly and
cross-sections were orthogonal to muscle myofilaments. Mitochondria do
not consistently localize to I-bands near neuromuscular junctions.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, two tables, Supplemental
Experimental Procedures, and four movies and can be found with this article
online at doi:10.1016/j.devcel.2011.12.009.
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